| Field | Specification |
|---|---|
| Applications | |
| Sensitivity | |
| Detection range | |
| Detection method | |
| Assay time | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Scientific Background
This ELISA kit applies to the in vitro quantitative determination of PGD2 concentrations in serum, plasma and other biological fluids.
Assay Principle
This ELISA kit uses the Competitive-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with Universal PGD2. During the reaction, Universal PGD2 in the sample or standard competes with a fixed amount of Universal PGD2 on the solid phase supporter for sites on the Biotinylated Detection Ab specific to Universal PGD2. Excess conjugate and unbound sample or standard are washed away, and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns from blue to yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of Universal PGD2 in tested samples can be calculated by comparing the OD of the samples to the standard curve.
Performance Specifications
| Sensitivity | 9.38 pg/mL |
|---|---|
| Detection Range | 15.63-1000 pg/mL |
| Total Assay Time | 2 h 30 min |
| Compatible Sample Types | Serum, plasma and other biological fluids |
| Species Reactivity | Universal (multi-species validated) |
| Detection Method | Competitive |
| Precision (CV) | Both intra-CV and inter-CV are < 10%. |
| Recovery Rate | 80%-120% |
| Storage | 2-8℃,12 months |
✓ Research-Grade Validation
Specificity
This kit recognizes Universal PGD2 in samples.No significant cross-reactivity or interference between Universal PGD2 and analogues was observed
Safety & Regulatory
Handle reagents in accordance with institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for complete hazard and handling information. Contains components that may require special disposal procedures per local regulations.
This kit is validated for use with Serum, plasma and other biological fluids. For unlisted matrices (e.g., tissue lysate, urine), perform a spike-and-recovery experiment to confirm assay performance before generating reportable data. Sample dilution in the kit's provided diluent is recommended to minimize matrix interference.
The minimum detectable concentration (sensitivity) of this kit is 9.38 pg/mL. Values below this threshold should be reported as below the limit of detection (<LOD) and should not be extrapolated from the standard curve.
The total assay time from sample addition to absorbance reading is approximately 2 h 30 min, including all incubation, wash, and substrate steps. Hands-on time is typically 1–2 hours; most steps involve passive plate incubation. Plan the assay as a single uninterrupted session for best results.
Standard components of this Competitive ELISA Kit typically include: pre-coated microplate (96-well strip format), lyophilized or liquid recombinant PGD2 standard, detection antibody, streptavidin-HRP conjugate, TMB substrate, stop solution, wash buffer concentrate, and sample/standard diluent. Refer to the kit insert or datasheet for the exact component list and storage requirements.
This kit uses colorimetric (TMB/HRP) detection and requires a standard microplate absorbance reader capable of measuring at 450 nm. A reference wavelength of 570 nm or 630 nm is recommended to reduce background. No specialized fluorescence or luminescence reader is needed. Ensure the instrument is calibrated and the plate is clean and free of condensation before reading.
These two belong to different types of prostaglandins. Prostaglandin E2 (PGE2) is the most abundant prostaglandin and is produced by the action of prostaglandin E synthetase on prostaglandin H2(PGH2). Prostaglandin D2(PGD2) is another prostaglandin produced by hematopoietic and lipoprotein prostaglandin D synthase (hPGDS and lPGDS) acting on prostaglandin H2(PGH2). In addition, the two have different receptors and different areas of study. PGE2: Mainly studies gastrointestinal smooth muscle PGD2: Studies allergic diseases such as asthma
Tissue samples may contain endogenous or exogenous proteases during processing, leading to degradation of extracted proteins. Therefore, it's necessary to add protease inhibitors during processing to ensure the integrity of target proteins. If customers can keep samples cold and handle them quickly during processing, omitting the protease inhibitor may not have a significant effect. After preparation, samples should be tested promptly or immediately aliquoted and frozen at -20°C or -80°C.
What is the range of enzyme activity of your IL-2 freeze-dried powder
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Resveratrol amplifies the anti-tumor effect of α-PD-1 by altering the intestinal microbiome and PGD2 content (2024) Gut Microbes. 10.1080/19490976.2024.2447821
PEPITEM Regulates the Synovial Microenvironment During Immune-Mediated Inflammatory Arthritis to Limit Disease (2026) Arthritis & Rheumatology. 10.1002/art.70108
A reverse translational approach reveals the protective roles of Mangifera indica in inflammatory bowel disease (2024) JOURNAL OF AUTOIMMUNITY. 10.1016/j.jaut.2024.103181
Thromboxane A2/Thromboxane A2 receptor axis facilitates hepatic insulin resistance and steatosis through ER stress in NAFLD (2023) BRITISH JOURNAL OF PHARMACOLOGY. 10.1111/bph.16238
Niacin-Loaded Liquid Crystal Nanoparticles Ameliorate Prostaglandin D2-Mediated Niacin-Induced Flushing and Hepatotoxicity (2024) ACS Applied Nano Materials. 10.1021/acsanm.3c04649
Overcoming drug delivery challenges with lipid-based nanofibers for enhanced wound repair (2024) Biomaterials Science. 10.1039/D4BM01536C
Enrichment of imidacloprid and its metabolites in lizards and its toxic effects on gonads (2019) ENVIRONMENTAL POLLUTION. 10.1016/j.envpol.2019.113748
Accumulation and toxicity of thiamethoxam and its metabolite clothianidin to the gonads of Eremias argus (2019) SCIENCE OF THE TOTAL ENVIRONMENT. 10.1016/j.scitotenv.2019.02.419
CKBA suppresses mast cell activation via ERK signaling pathway in murine atopic dermatitis (2023) EUROPEAN JOURNAL OF IMMUNOLOGY. 10.1002/eji.202350374
Rosmarinic acid treatment protects against lethal H1N1 virus-mediated inflammation and lung injury by promoting activation of the h-PGDS-PGD2-HO-1 signal axis (2023) Chinese Medicine. 10.1186/s13020-023-00847-0
Therapeutic Potential of Molsidomine-Loaded Liquid Crystal Nanoparticles for the Treatment and Management of Niacin-Induced Varicose Veins: In Vitro and In Vivo Studies (2024) ACS Applied Bio Materials. 10.1021/acsabm.4c00980
Dexamethasone-Loaded Thermosensitive Hydrogel Suppresses Inflammation and Pain in Collagen-Induced Arthritis Rats (2022) Drug Design Development and Therapy. 10.2147/DDDT.S256850
Analysis of daily aspirin intake on platelet-associated factors and aggregation in nonsteroidal anti-inflammatory drug exacerbated respiratory disease: A cross-sectional study (2025) ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY. 10.12932/AP-261024-1959
